SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001753926-24-000266
Filing Date
2024-02-12
Accepted
2024-02-12 08:02:12
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A g084025_s1a.htm S-1/A 2729076
2 EXHIBIT 4.32 g084025_ex4-32.htm EX-4.32 23554
3 EXHIBIT 4.33 g084025_ex4-33.htm EX-4.33 22595
4 EXHIBIT 4.34 g084025_ex4-34.htm EX-4.34 17981
5 EXHIBIT 5.1 g084025_ex5-1.htm EX-5.1 23464
6 EXHIBIT 23.1 g084025_ex23-1.htm EX-23.1 4989
7 EXHIBIT 107 g084025_ex107.htm EX-FILING FEES 18868
8 GRAPHIC img001_v2.jpg GRAPHIC 3676
9 GRAPHIC img001_v1.jpg GRAPHIC 3591
10 GRAPHIC img002_v1.jpg GRAPHIC 6503
  Complete submission text file 0001753926-24-000266.txt   2860915
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-269188 | Film No.: 24617430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)